Me. Vandort et al., SYNTHESIS OF THE I-123 LABELED AND I-125 LABELED CHOLINERGIC NERVE MARKER (-)-5-IODOBENZOVESAMICOL, Nuclear medicine and biology, 20(8), 1993, pp. 929-937
The highly toxic curaremimetic and cholinergic neuron marker (-)-5-iod
obenzovesamicol (IBVM) has been labeled with iodine-125 and iodine-123
. [I-125]IBVM, suitable for animal distribution and ex vivo autoradiog
raphic studies, was synthesized by solid-state exchange; isolated yiel
ds were 65-89% with specific activities in the range of 130-200 Ci/mmo
l. The synthesis of no-carrier-added (-)-5-[I-125]IBVM from the corres
ponding chiral (-)-5-(tri-n-butyltin) derivative using (NaI)-I-125 was
evaluated using the oxidants H2O2, peracetic acid and chloramine-T. B
oth peracetic acid and chloramine-T gave good yields (70-95%). However
, when (NaI)-I-123 Was utilized, acceptable yields of [I-123]IBVM were
obtained only with chloramine-T. Use of the latter oxidant did produc
e 5-chlorobenzovesamicol which was eliminated during HPLC purification
. After optimization of the reaction parameters, [I-123]IBVM in batch
sizes of 10-27 mCi, is routinely obtained with a specific activity of
30-70,000 Ci/mmol, radiochemical purity (> 97%) and chiral purity (> 9
8 %). Isolated radiochemical yields have averaged 71 % (N = 40). Distr
ibution analyses of [I-125]IBVM and [I-123]IBVM in mice 4 h following
intravenous administration show essentially equivalent concentrations
of the two tracers in the four brain regions sampled. The exceptionall
y high specific activity of [I-123]IBVM has made possible the evaluati
on of this radiotracer in humans.